Novel Spectacle Lenses for Myopia
(EUCALYPTUS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the effectiveness of new spectacle lenses for children with myopia (nearsightedness). The study will compare two groups of children wearing single vision, impact-resistant lenses over 12 months, with predictions extending up to three years. It seeks children aged 6 to 8 with a specific range of myopia who are willing to wear the glasses regularly. Participants should not have worn contact lenses before and must not have used other myopia treatments. The researchers aim to confirm findings from earlier trials and improve future myopia management. As an unphased trial, this study offers a unique opportunity for children to contribute to advancing myopia management strategies.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are using any myopia control treatments like atropine, you would not be eligible to participate.
What prior data suggests that these spectacle lenses are safe for children?
Research shows that single vision, impact-resistant glasses are generally well-tolerated. Studies on similar glasses have examined their ability to slow the progression of nearsightedness in children. While these studies primarily assess effectiveness, they also provide crucial safety information.
For instance, a study with children from North America and China found that these glasses effectively slowed nearsightedness over a year, with no major safety concerns reported. Another long-term study on similar glasses, known as DIMS lenses, demonstrated continued control of nearsightedness over six years, again without significant safety issues.
Overall, these findings suggest that the glasses used in this trial are likely safe for children. They have been tested in various settings and have not caused notable side effects.12345Why are researchers excited about this trial?
Researchers are excited about these spectacle lenses for myopia because they combine single vision correction with impact-resistant materials, offering durability alongside vision improvement. Unlike traditional lenses that may not withstand physical stress, these lenses are designed to be more resilient, making them ideal for active lifestyles. This combination could enhance the quality of life for people with myopia by providing clearer vision with added protection.
What evidence suggests that these spectacle lenses could be effective for myopia?
Research has shown that special glasses designed to control nearsightedness (myopia) can help slow its progression in children. Studies have found that these glasses significantly reduce the growth of the eye's length from front to back, which is linked to worsening myopia, compared to regular glasses. One study discovered that these special lenses reduced the worsening of myopia in schoolchildren within a year. Another study over five years showed that these lenses effectively slowed myopia progression. This trial will test single vision, impact-resistant spectacle lenses designed to manage myopia in children. These findings suggest that specially designed glasses could be a promising way to manage myopia in children.36789
Are You a Good Fit for This Trial?
This trial is for children aged 6-8 with mild to moderate near-sightedness (myopia) who have good vision with glasses and no more than a small difference in prescription between their eyes. They must be able to wear the study glasses at least 10 hours a day, not use contact lenses, and have no eye conditions or systemic diseases affecting vision.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive single vision, impact-resistant spectacle lenses
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Single vision, impact-resistant spectacle lenses
Find a Clinic Near You
Who Is Running the Clinical Trial?
SightGlass Vision, Inc.
Lead Sponsor